Mesoporous bioactive glass surface modified poly(lactic-co-glycolic acid) electrospun fibrous scaffold for bone regeneration

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 3815-3827

  Chen, Shijie ^a   Jian, Zhiyuan ^b   Huang, Linsheng ^b   Xu, Wei ^c   Liu, Shaohua ^d   Song, Dajiang ^c   Wan, Zongmiao ^c   Vaughn, Amanda ^e   Zhan, Ruisen ^a   Zhang, Chaoyue ^a   Wu, Song ^a   Hu, Minghua ^f   Li, Jinsong ^a  

^a THE THIRD XIANGYA HOSPITAL OF CENTRAL SOUTH UNIVERSITY   (China)

^b University of Medicine   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

^d CENTRAL SOUTH UNIVERSITY   (China)

^e UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^f CHANGSHA MEDICAL UNIVERSITY   (China)

Author keywords

BMP 2; Bone regeneration; Mesoporous; Scaffolds; Stem cells

Indexed keywords

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; HYDROXYAPATITE; MESOPOROUS BIOACTIVE GLASS; POLYGLACTIN; UNCLASSIFIED DRUG; BMP2 PROTEIN, HUMAN; GLASS; LACTIC ACID; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER;

ADSORPTION; ARTICLE; BIOLOGICAL ACTIVITY; BONE DEVELOPMENT; BONE REGENERATION; CELL PROLIFERATION; CHEMICAL COMPOSITION; CHEMICAL MODIFICATION; CONTROLLED STUDY; ELECTROSPINNING; HUMAN; HUMAN CELL; HYDROPHILICITY; IN VITRO STUDY; MESENCHYMAL STEM CELL; POROSITY; PROTEIN SECRETION; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; CELL DIFFERENTIATION; CHEMISTRY; CYTOLOGY; MATERIALS TESTING; MESENCHYMAL STROMA CELL; PHYSIOLOGY; TISSUE SCAFFOLD;

LAKE VICTORIA MARBURGVIRUS;

BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; DURAPATITE; GLASS; HUMANS; LACTIC ACID; MATERIALS TESTING; MESENCHYMAL STROMAL CELLS; OSTEOGENESIS; POLYGLYCOLIC ACID; POROSITY; SURFACE PROPERTIES; TISSUE SCAFFOLDS;

EID: 84933567351     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S82543     Document Type: Article

References (58)

1. Cordonnier T, Sohier J, Rosset P, Layrolle P. Biomimetic materials for bone tissue engineering–state of the art and future trends. Adv Eng Mater. 2011;13(5):B135–B150.
2. Weatherholt AM, Fuchs RK, Warden SJ. Specialized connective tissue: bone, the structural framework of the upper extremity. J Hand Ther. 2012;25(2):123–132.
3. Finkemeier CG. Bone-grafting and bone-graft substitutes. J Bone Joint Surg Am. 2002;84-A(3):454–464.
4. Greenwald AS, Boden SD, Goldberg VM, Khan Y, Laurencin CT, Rosier RN; American Academy of Orthopaedic Surgeons; The Committee on Biological Implants. Bone-graft substitutes: facts, fctions, and applications. J Bone Joint Surg Am. 2001;83-ASuppl 2 Pt 2:S98–S103.
5. Gao C, Deng Y, Feng P, et al. Current progress in bioactive ceramic scaffolds for bone repair and regeneration. Int J Mol Sci. 2014;15(3): 4714–4732.
6. Dahlin C, Johansson A, Hoffman M, Molenberg A. Early biocompat-ibility of poly(ethylene glycol) hydrogel barrier materials for guided bone regeneration. An in vitro study using human gingival fbroblasts (HGF-1). Clin Oral Implants Res. 2014;25(1):16–20.
7. Hickman GJ, Rees RC, Boocock DJ, Pockley AG, Perry CC. Controlling the dynamics of cell transition in heterogeneous cultures using surface chemistry. Adv Healthc Mater. 2015;4(4):593–601.
8. Shen Y, Gao M, Ma Y, et al. Effect of surface chemistry on the integrin induced pathway in regulating vascular endothelial cells migration. Colloids Surf B Biointerfaces. 2015;126:188–197.
9. Stevens MM, George JH. Exploring and engineering the cell surface interface. Science. 2005;310(5751):1135–1138.
10. Delaine-Smith RM, Green NH, Matcher SJ, MacNeil S, Reilly GC. Monitoring fbrous scaffold guidance of three-dimensional collagen organisation using minimally-invasive second harmonic generation. PloS One. 2014;9(2):e89761.
11. Gentile P, Chiono V, Carmagnola I, Hatton PV. An overview of poly (lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering. Int J Mol Sci. 2014;15(3):3640–3659.
12. Chung YI, Kim JC, Kim YH, et al. The effect of surface functionalization of PLGA nanoparticles by heparin- or chitosan-conjugated Pluronic on tumor targeting. J Control Release. 2010;143(3): 374–382.
13. Jose MV, Thomas V, Johnson KT, Dean DR, Nyairo E. Aligned PLGA/ HA nanofbrous nanocomposite scaffolds for bone tissue engineering. Acta Biomater. 2009;5(1):305–315.
14. Kong C, Lee T, Lee S, Kim HS. Nano-web formation by the electro-spinning at various electric fields. J Mater Sci. 2007;42(19): 8106–8112.
15. De Vrieze S, Westbroek P, Van Camp T, De Clerck K. Solvent system for steady state electrospinning of polyamide 6.6. J Appl Polym Sci. 2010;115(2):837–842.
16. Wang Y, Li H, Wang G, Yin T, Wang B, Yu Q. Electrospinning of polymer nanofbers with ordered patterns and architectures. J Nanosci Nanotechnol. 2010;10(3):1699–1706.
17. Duan B, Yuan X, Zhu Y, et al. A nanofbrous composite membrane of PLGA–chitosan/PVA prepared by electrospinning. Eur Polym J. 2006; 42(9):2013–2022.
18. Min BM, Yo u Y, Kim JM, Lee SJ, Park WH. Formation of nano-structured poly(lactic-co-glycolic acid)/chitin matrix and its cellular response to normal human keratinocytes and fbroblasts. Carbohydr Polym. 2004;57(3):285–292.
19. Meng ZX, Wang YS, Ma C, Zheng W, Li L, Zheng YF. Electrospin-ning of PLGA/gelatin randomly-oriented and aligned nanofbers as potential scaffold in tissue engineering. Mater Sci Eng C Mater Biol Appl. 2010;30(8):1204–1210.
20. Wu C, Zhang Y, Fan W, et al. CaSiO3 microstructure modulating the in vitro and in vivo bioactivity of poly(lactide-co-glycolide) micro-spheres. J Biomed Mater Res A. 2011;98(1):122–131.
21. Zhao L, Lin K, Zhang M, et al. The infuences of poly(lactic-co-glycolic acid) (PLGA) coating on the biodegradability, bioactivity, and biocompatibility of calcium silicate bioceramics. J Mater Sci. 2011; 46(14):4986–4993.
22. Zhao L, Wu C, Lin K, Chang J. The effect of poly(lactic-co-glycolic acid) (PLGA) coating on the mechanical, biodegradable, bioactive properties and drug release of porous calcium silicate scaffolds. Biomed Mater Eng. 2012;22(5):289–300.
23. Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel). 2011;3(3): 1377–1397.
24. Hild N, Tawakoli PN, Halter JG, et al. pH-dependent antibacterial effects on oral microorganisms through pure PLGA implants and composites with nanosized bioactive glass. Acta Biomater. 2013;9(11): 9118–9125.
25. Liu G, Wu C, Fan W, et al. The effects of bioactive akermanite on phys-iochemical, drug-delivery, and biological properties of poly(lactide-co-glycolide) beads. J Biomed Mater Res B Appl Biomater. 2011;96(2): 360–368.
26. Tai IC, Fu YC, Wang CK, Chang JK, Ho ML. Local delivery of controlled-release simvastatin/PLGA/HAp microspheres enhances bone repair. Int J Nanomedicine. 2013;8:3895–3904.
27. Tang G, Zhang H, Zhao Y, Li X, Yuan X, Wang M. Prolonged release from PLGA/HAp scaffolds containing drug-loaded PLGA/ gelatin composite microspheres. J Mater Sci Mater Med. 2012;23(2): 419–429.
28. Kim J, McBride S, Tellis B, et al. Rapid-prototyped PLGA/β-TCP/ hydroxyapatite nanocomposite scaffolds in a rabbit femoral defect model. Biofabrication. 2012;4(2):025003.
29. Yoshida T, Miyaji H, Otani K, et al. Bone augmentation using a highly porous PLGA/β-TCP scaffold containing fbroblast growth factor-2. J Periodontal Res. 2015;50(2):265–273.
30. Shim JH, Yoon MC, Jeong CM, et al. Effcacy of rhBMP-2 loaded PCL/PLGA/β-TCP guided bone regeneration membrane fabricated by 3D printing technology for reconstruction of calvaria defects in rabbit. Biomed Mater. 2014;9(6):065006.
31. Filipowska J, Pawlik J, Cholewa-Kowalska K, et al. Incorporation of sol–gel bioactive glass into PLGA improves mechanical properties and bioactivity of composite scaffolds and results in their osteoinductive properties. Biomed Mater. 2014;9(6):065001.
32. Nazemi K, Azadpour P, Moztarzadeh F, Urbanska AM, Mozafari M. Tissue-engineered chitosan/bioactive glass bone scaffolds integrated with PLGA nanoparticles: a therapeutic design for on-demand drug delivery. Mater Lett. 2015;138:16–20.
33. Wu C, Ramaswamy Y, Zhu Y, et al. The effect of mesoporous bioac-tive glass on the physiochemical, biological and drug-release properties of poly(DL-lactide-co-glycolide) flms. Biomaterials. 2009;30(12): 2199–2208.
34. Wu C, Zhou Y, Fan W, et al. Hypoxia-mimicking mesoporous bioac-tive glass scaffolds with controllable cobalt ion release for bone tissue engineering. Biomaterials. 2012;33(7):2076–2085.
35. Ya n X, Huang X, Yu C, et al. The in-vitro bioactivity of mesoporous bioactive glasses. Biomaterials. 2006;27(18):3396–3403.
36. Izquierdo-Barba I, Ruiz-González L, Doadrio JC, González-Calbet JM, Vallet-Regí M. Tissue regeneration: a new property of mesoporous materials. Solid State Sci. 2005;7(8):983–989.
37. Wu C, Zhang Y, Zhu Y, Friis T, Xiao Y. Structure–property relationships of silk-modifed mesoporous bioglass scaffolds. Biomaterials. 2010;31(13):3429–3438.
38. Trejo CG, Lozano D, Manzano M, et al. The osteoinductive properties of mesoporous silicate coated with osteostatin in a rabbit femur cavity defect model. Biomaterials. 2010;31(33):8564–8573.
39. Wei G, Jin Q, Giannobile WV, Ma PX. Nano-fbrous scaffold for controlled delivery of recombinant human PDGF-BB. J Control Release. 2006;112(1):103–110.
40. Dimitriou R, Jones E, McGonagle D, Giannoudis PV. Bone regeneration: current concepts and future directions. BMC Med. 2011;9:66.
41. Wu C, Chang J. Multifunctional mesoporous bioactive glasses for effective delivery of therapeutic ions and drug/growth factors. J Control Release. 2014;193:282–295.
42. Dai C, Guo H, Lu J, Shi J, Wei J, Liu C. Osteogenic evaluation of calcium/magnesium-doped mesoporous silica scaffold with incorporation of rhBMP-2 by synchrotron radiation-based μCT. Biomaterials. 2011; 32(33):8506–8517.
43. Zhou P, Cheng X, Xia Y, et al. Organic/inorganic composite membranes based on poly(L-lactic-co-glycolic acid) and mesoporous silica for effective bone tissue engineering. Acs Appl Mater Interfaces. 2014; 6(23):20895–20903.
44. Zhu M, Zhang L, He Q, Zhao J, Limin G, Shi J. Mesoporous bioac-tive glass-coated poly(l-lactic acid) scaffolds: a sustained antibiotic drug release system for bone repairing. J Mater Chem. 2011;21(4): 1064–1072.
45. Janitabar-Darzi S. Structural and photocatalytic activity of mes-oporous N-doped TiO2 with band-to-band visible light absorption ability. Particulate Science and Technology: An International Journal. 2014;32(5):506–511.
46. Kokubo T, Kushitani H, Sakka S, Kitsugi T, Yamamuro T. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W. J Biomed Mater Res. 1990;24(6):721–734.
47. Duan B, Yuan X, Zhu Y, et al. A nanofbrous composite membrane of PLGA–chitosan/PVA prepared by electrospinning. Eur Polym J. 2006;42(9):2013–2022.
48. Stanford CM, Jacobson PA, Eanes ED, Lembke LA, Midura RJ. Rapidly forming apatitic mineral in an osteoblastic cell line (UMR 106-01 BSP). J Biol Chem. 1995;270(16):9420–9428.
49. Danilevicius P, Georgiadi L, Pateman CJ, Claeyssens F, Chatzinikolaidou M, Farsari M. The effect of porosity on cell ingrowth into accurately defned, laser-made, polylactide-based 3D scaffolds. Appl Surf Sci. 2015; 336:1–10.
50. Krishnan L, Touroo J, Reed R, Boland E, Hoying JB, Williams SK. Vascularization and cellular isolation potential of a novel electro-spun cell delivery vehicle. J Biomed Mater Res A. 2014;102(7): 2208–2219.
51. Shi C, Yuan W, Khan M, et al. Hydrophilic PCU scaffolds prepared by grafting PEGMA and immobilizing gelatin to enhance cell adhesion and proliferation. Mater Sci Eng C Mater Biol Appl. 2015;50:201–209.
52. Kraus D, Deschner J, Jäger A, et al. Human β-defensins differently affect proliferation, differentiation, and mineralization of osteoblast-like MG63 cells. J Cell Physiol. 2012;227(3):994–1003.
53. Mikulska A, Filipowska J, Osyczka AM, Nowakowska M, Szczubiałka K. Osteoinductive activity of insulin-functionalized cell culture surfaces obtained using diazonium chemistry. Front Chem. 2015;2:117.
54. Wang Z, Wang K, Lu X, et al. BMP-2 encapsulated polysaccharide nanoparticle modifed biphasic calcium phosphate scaffolds for bone tissue regeneration. J Biomed Mater Res A. 2015;103(4):1520–1532.
55. Phipps MC, Clem WC, Grunda JM, Clines GA, Bellis SL. Increasing the pore sizes of bone-mimetic electrospun scaffolds comprised of polycaprolactone, collagen I and hydroxyapatite to enhance cell infltration. Biomaterials. 2012;33(2):524–534.
56. Rahman CV, Ben-David D, Dhillon A, et al. Controlled release of BMP-2 from a sintered polymer scaffold enhances bone repair in a mouse calva-rial defect model. J Tissue Eng Regen Med. 2014;8(1):59–66.
57. Seo BB, Choi H, Koh JT, Song SC. Sustained BMP-2 delivery and injectable bone regeneration using thermosensitive polymeric nanopar-ticle hydrogel bearing dual interactions with BMP-2. J Control Release. 2015;209:67–76.
58. Zhang Q, Zhang Y, Chen W, Zhang B, Wang S. Long-term controlled release of 125I-tagged BMP-2 by mesoporous bioactive glass with ordered nanopores. Exp Ther Med. 2013;6(6):1443–1448.